Human Glucose Transp. 10 (Glut-10) Control/blocking peptide # 1
General Information
Human Glut-10 (541 aa, chromosome 20q13.1; ~30-35% homology with Glut-3 and Glut-8) has been identified as a candidate gene for NIDDM susceptibility. It is widely expressed with highest levels in liver and pancreas. FUNCTION: Facilitative glucose transp
SugApplications
Control or blocking peptides are recommended for ELISA plate coating for direct ELISA testing of antibodies or competitive ELISA, and antibody blocking or neutralization.
SpeciesReactivity
Human
Form
Antigen/blocking Peptide
Antigen
16-aa peptide from Human Glut-10 (protein accession #O95528, refs 1) (1); Designation (GT101-P, control peptide or control peptide).conjugated to KLH; Epitope location~ C-terminal, Cytoplasmic domain
SpCrossreactivity
Human GT101-P peptide sequence is 53% conserved in mouse Glut-10. No significant sequence homology with other gluts. Antibody crossreactivity in various species is not established.
For research use only, not for diagnostic or therapeutic use.
| Alpha Diagnostic International, Inc. | |
|---|---|
| Product Category | Biological Materials |
| Product Number | GT101-P |
| Product Name | Human Glucose Transp. 10 (Glut-10) Control/blocking peptide # 1 |